-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on HCA Healthcare, Lowers Price Target to $579

Benzinga·07/27/2026 18:18:53
Listen to the news
UBS analyst A.J. Rice maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $635 to $579.